BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:36 PM
 | 
Nov 17, 2008
 |  BC Extra  |  Company News

Mixed bag for rufinamide

Eisai (Tokyo:4523; Osaka:4523) said FDA approved an NDA for Banzel rufinamide for the adjunctive treatment of seizures associated...

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >